Connor A et al. |
Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure. |
2012 |
Transplantation |
pmid:23318306
|
Plock JA et al. |
Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. |
2015 |
Transplantation |
pmid:26102613
|
Gurk-Turner C et al. |
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. |
2008 |
Transplantation |
pmid:18497682
|
Khanafer A et al. |
Increased nitric oxide production during acute rejection in kidney transplantation: a useful marker to aid in the diagnosis of rejection. |
2007 |
Transplantation |
pmid:17876269
|
Singh N et al. |
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. |
2000 |
Transplantation |
pmid:10708096
|
Haririan A et al. |
Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. |
2003 |
Transplantation |
pmid:12717201
|
Gonwa T et al. |
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. |
2003 |
Transplantation |
pmid:12717205
|
Taber DJ et al. |
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. |
2017 |
Transplantation |
pmid:28658199
|
Diémé B et al. |
Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling. |
2014 |
Transplantation |
pmid:24598938
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
Stegall MD et al. |
Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. |
1997 |
Transplantation |
pmid:9422404
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Demmers MW et al. |
Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells. |
2014 |
Transplantation |
pmid:24704664
|
Shibutani S et al. |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. |
2005 |
Transplantation |
pmid:15849542
|
Tory R et al. |
Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations. |
2009 |
Transplantation |
pmid:19584682
|
Manitpisitkul W et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. |
2009 |
Transplantation |
pmid:19584685
|
Weiler N et al. |
Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial. |
2010 |
Transplantation |
pmid:21048536
|
Chisholm MA et al. |
Renal transplant patient compliance with free immunosuppressive medications. |
2000 |
Transplantation |
pmid:11063348
|
Dominguez J et al. |
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. |
2000 |
Transplantation |
pmid:11063349
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Barraclough KA et al. |
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. |
2012 |
Transplantation |
pmid:23095803
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Hoogduijn MJ et al. |
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. |
2008 |
Transplantation |
pmid:19005411
|
Tzakis AG et al. |
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. |
2004 |
Transplantation |
pmid:15114087
|
Serón D et al. |
Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. |
2007 |
Transplantation |
pmid:17353788
|
Talbot D et al. |
Alopecia as a consequence of tacrolimus therapy in renal transplantation? |
1997 |
Transplantation |
pmid:9415574
|
Gregory CR et al. |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. |
1995 |
Transplantation |
pmid:7533955
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Vossen M et al. |
Bone quality in swine composite tissue allografts: effects of combination immunotherapy. |
2005 |
Transplantation |
pmid:16123723
|
Suzuki S et al. |
Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7685932
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Lauria MW et al. |
Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations. |
2010 |
Transplantation |
pmid:20061923
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Pascual M et al. |
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. |
1998 |
Transplantation |
pmid:9869086
|
Ciancio G et al. |
Review of major clinical trials with mycophenolate mofetil in renal transplantation. |
2005 |
Transplantation |
pmid:16251852
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Baran DA et al. |
Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol. |
2002 |
Transplantation |
pmid:12438960
|
Kasahara M et al. |
Role of HLA compatibility in pediatric living-related liver transplantation. |
2002 |
Transplantation |
pmid:12438966
|
Hudnall SD |
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A? |
2002 |
Transplantation |
pmid:12369583
|
Arai K et al. |
Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. |
1989 |
Transplantation |
pmid:2479130
|
Kawano K et al. |
A protective effect of FK506 in ischemically injured rat livers. |
1991 |
Transplantation |
pmid:1713362
|
de Jonge H et al. |
Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation. |
2010 |
Transplantation |
pmid:20592652
|
Shibasaki S et al. |
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway. |
2013 |
Transplantation |
pmid:23269193
|
Yuzawa K and Fukao K |
Topical FK506 ointment for skin grafting. |
1998 |
Transplantation |
pmid:9565111
|
Puig I Marà JM et al. |
Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus. |
2000 |
Transplantation |
pmid:10919604
|
Erickson LM et al. |
Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. |
2003 |
Transplantation |
pmid:12923448
|
Markus PM et al. |
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. |
1991 |
Transplantation |
pmid:1718063
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|